Overview of mitochondrial germline variants and mutations in human disease: Focus on breast cancer (Review)
- Authors:
- Silvia Jiménez-Morales
- Carlos J. Pérez-Amado
- Elizabeth Langley
- Alfredo Hidalgo-Miranda
-
Affiliations: Laboratory of Cancer Genomics, National Institute of Genomic Medicine, 14610 Mexico City, Mexico, Biochemistry Sciences Program, National Autonomous University of Mexico, 04510 Mexico City, Mexico, Department of Basic Research, National Cancer Institute, 14080 Mexico City, Mexico - Published online on: July 4, 2018 https://doi.org/10.3892/ijo.2018.4468
- Pages: 923-936
This article is mentioned in:
Abstract
 |
 |
|
World Cancer Research Fund International: BC Statistics: http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/breast-cancer-statistics Accessed January 19, 2018. | |
|
Breastcancer.org: U.S. BC statistics: http://www.breastcancer.org/symptoms/understand_bc/statistics. Accessed January 19, 2018. | |
|
Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Warburg O: On the origin of cancer cells. Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI | |
|
Havas KM, Milchevskaya V, Radic K, Alladin A, Kafkia E, Garcia M, Stolte J, Klaus B, Rotmensz N, Gibson TJ, et al: Metabolic shifts in residual breast cancer drive tumor recurrence. J Clin Invest. 127:2091–2105. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wu W and Zhao S: Metabolic changes in cancer: Beyond the Warburg effect. Acta Biochim Biophys Sin (Shanghai). 45:18–26. 2013. View Article : Google Scholar | |
|
Bardella C, Pollard PJ and Tomlinson I: SDH mutations in cancer. Biochim Biophys Acta. 1807:1432–1443. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bogenhagen DF: Mitochondrial DNA nucleoid structure. Biochim Biophys Acta. 1819:914–920. 2012. View Article : Google Scholar | |
|
Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM and Howell N: Reanaly-sis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet. 23:1471999. View Article : Google Scholar | |
|
Wallace DC and Chalkia D: Mitochondrial DNA genetics and the heteroplasmy conundrum in evolution and disease. Cold Spring Harb Perspect Biol. 5:a0212202013. View Article : Google Scholar : PubMed/NCBI | |
|
Stewart JB and Chinnery PF: The dynamics of mitochondrial DNA heteroplasmy: Implications for human health and disease. Nat Rev Genet. 16:530–542. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Akhmedov AT and Marín-García J: Mitochondrial DNA maintenance: An appraisal. Mol Cell Biochem. 409:283–305. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Yakes FM and Van Houten B: Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc Natl Acad Sci USA. 94:514–519. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Egea PF, Stroud RM and Walter P: Targeting proteins to membranes: Structure of the signal recognition particle. Curr Opin Struct Biol. 15:213–220. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Baker MJ, Frazier AE, Gulbis JM and Ryan MT: Mitochondrial protein-import machinery: Correlating structure with function. Trends Cell Biol. 17:456–464. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Neupert W and Herrmann JM: Translocation of proteins into mitochondria. Annu Rev Biochem. 76:723–749. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Lill R and Mühlenhoff U: Maturation of iron-sulfur proteins in eukaryotes: Mechanisms, connected processes, and diseases. Annu Rev Biochem. 77:669–700. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Virbasius JV and Scarpulla RC: Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: A potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. Proc Natl Acad Sci USA. 91:1309–1313. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Hendrickson SL, Lautenberger JA, Chinn LW, Malasky M, Sezgin E, Kingsley LA, Goedert JJ, Kirk GD, Gomperts ED, Buchbinder SP, et al: Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. PLoS One. 5:e128622010. View Article : Google Scholar : PubMed/NCBI | |
|
Scarpulla RC: Nucleus-encoded regulators of mitochondrial function: Integration of respiratory chain expression, nutrient sensing and metabolic stress. Biochim Biophys Acta. 1819:1088–1097. 2012. View Article : Google Scholar : | |
|
Kasashima K and Endo H: Interaction of human mitochondrial transcription factor A in mitochondria: Its involvement in the dynamics of mitochondrial DNA nucleoids. Genes Cells. 20:1017–1027. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lee HC and Wei YH: Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol. 37:822–834. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Hance N, Ekstrand MI and Trifunovic A: Mitochondrial DNA polymerase gamma is essential for mammalian embryogenesis. Hum Mol Genet. 14:1775–1783. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Mokranjac D and Neupert W: Cell biology: Architecture of a protein entry gate. Nature. 528:201–202. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fan AC, Bhangoo MK and Young JC: Hsp90 functions in the targeting and outer membrane translocation steps of Tom70-mediated mitochondrial import. J Biol Chem. 281:33313–33324. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
MacKenzie JA and Payne RM: Mitochondrial protein import and human health and disease. Bi-ochim Biophys Acta. 1772:509–523. 2007. | |
|
Bandiera S, Rüberg S, Girard M, Cagnard N, Hanein S, Chrétien D, Munnich A, Lyonnet S and Henrion-Caude A: Nuclear outsourcing of RNA interference components to human mitochondria. PLoS One. 6:e207462011. View Article : Google Scholar : PubMed/NCBI | |
|
Stefano GB and Kream RM: Mitochondrial DNA heteroplasmy in human health and disease. Biomed Rep. 4:259–262. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hudson G, Gomez-Duran A, Wilson IJ and Chinnery PF: Recent mitochondrial DNA mutations increase the risk of developing common late-onset human diseases. PLoS Genet. 10:e10043692014. View Article : Google Scholar : PubMed/NCBI | |
|
Hudson G, Carelli V, Spruijt L, Gerards M, Mowbray C, Achilli A, Pyle A, Elson J, Howell N, La Morgia C, et al: Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA-haplogroup background. Am J Hum Genet. 81:228–233. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Soini HK, Moilanen JS, Vilmi-Kerälä T, Finnilä S and Majamaa K: Mitochondrial DNA variant m.15218A >G in Finnish epilepsy patients who have maternal relatives with epilepsy, sensorineural hearing impairment or diabetes mellitus. BMC Med Genet. 14:732013. View Article : Google Scholar | |
|
Fragaki K, Procaccio V, Bannwarth S, Serre V, O'Hearn S, Potluri P, Augé G, Casagrande F, Caruba C, Lambert JC, et al: A neonatal polyvisceral failure linked to a de novo homoplasmic mutation in the mitochondrially encoded cytochrome b gene. Mitochondrion. 9:346–352. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ghezzi D, Marelli C, Achilli A, Goldwurm S, Pezzoli G, Barone P, Pellecchia MT, Stanzione P, Brusa L, Bentivoglio AR, et al: Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet. 13:748–752. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Huerta C, Castro MG, Coto E, Blázquez M, Ribacoba R, Guisasola LM, Salvador C, Martínez C, Lahoz CH and Alvarez V: Mitochondrial DNA polymorphisms and risk of Parkinson's disease in Spanish population. J Neurol Sci. 236:49–54. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Galmiche L, Serre V, Beinat M, Assouline Z, Lebre AS, Chretien D, Nietschke P, Benes V, Boddaert N, Sidi D, et al: Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy. Hum Mutat. 32:1225–1231. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Götz A, Tyynismaa H, Euro L, Ellonen P, Hyötyläinen T, Ojala T, Hämäläinen RH, Tommiska J, Raivio T, Oresic M, et al: Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet. 88:635–642. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Bayat V, Thiffault I, Jaiswal M, Tétreault M, Donti T, Sasarman F, Bernard G, Demers-Lamarche J, Dicaire MJ, Mathieu J, et al: Mutations in the mitochondrial methionyl-tRNA synthetase cause a neurodegenerative phenotype in flies and a recessive ataxia (ARSAL) in humans. PLoS Biol. 10:e10012882012. View Article : Google Scholar : PubMed/NCBI | |
|
Elo JM, Yadavalli SS, Euro L, Isohanni P, Götz A, Carroll CJ, Valanne L, Alkuraya FS, Uusimaa J, Paetau A, et al: Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet. 21:4521–4529. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Haack TB, Kopajtich R, Freisinger P, Wieland T, Rorbach J, Nicholls TJ, Baruffini E, Walther A, Danhauser K, Zimmermann FA, et al: ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy. Am J Hum Genet. 93:211–223. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Soiferman D, Ayalon O, Weissman S and Saada A: The effect of small molecules on nuclear-encoded translation diseases. Biochimie. 100:184–191. 2014. View Article : Google Scholar | |
|
Powell CA, Nicholls TJ and Minczuk M: Nuclear-encoded factors involved in post-transcriptional processing and modification of mitochondrial tRNAs in human disease. Front Genet. 6:792015. View Article : Google Scholar : PubMed/NCBI | |
|
Takakubo F, Cartwright P, Hoogenraad N, Thorburn DR, Collins F, Lithgow T and Dahl HH: An amino acid substitution in the pyruvate dehydrogenase E1 alpha gene, affecting mitochondrial import of the precursor protein. Am J Hum Genet. 57:772–780. 1995.PubMed/NCBI | |
|
Weraarpachai W, Sasarman F, Nishimura T, Antonicka H, Auré K, Rötig A, Lombès A and Shoubridge EA: Mutations in C12orf62, a factor that couples COX I synthesis with cytochrome c oxidase assembly, cause fatal neonatal lactic acidosis. Am J Hum Genet. 90:142–151. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Larman TC, DePalma SR, Hadjipanayis AG, Protopopov A, Zhang J, Gabriel SB, Chin L, Seidman CE, Kucherlapati R and Seidman JG; Cancer Genome Atlas Research Network: Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci USA. 109:14087–14091. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Kenny TC, Hart P, Ragazzi M, Sersinghe M, Chipuk J, Sagar MA, Eliceiri KW, LaFramboise T, Grandhi S, Santos J, et al: Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPRmt to promote metastasis. Oncogene. 36:4393–4404. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ahn EH, Hirohata K, Kohrn BF, Fox EJ, Chang CC and Loeb LA: Detection of ultrarare mitochondrial mutations in breast stem cells by duplex sequencing. PLoS One. 10:e01362162015. View Article : Google Scholar | |
|
Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW and Vogelstein B: Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat Genet. 20:291–293. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Yadav N and Chandra D: Mitochondrial DNA mutations and breast tumorigenesis. Biochim Bi-ophys Acta. 1836:336–344. 2013. | |
|
Pedersen PL, Mathupala S, Rempel A, Geschwind JF and Ko YH: Mitochondrial bound type II hexokinase: A key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta. 1555:14–20. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Brandon M, Baldi P and Wallace DC: Mitochondrial mutations in cancer. Oncogene. 25:4647–4662. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kirches E: Mitochondrial and nuclear genes of mitochondrial components in cancer. Curr Genomics. 10:281–293. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kenny TC and Germain D: mtDNA, metastasis, and the mitochondrial unfolded protein response (UPRmt). Front Cell Dev Biol. 5:372017. View Article : Google Scholar : | |
|
Habano W, Sugai T, Yoshida T and Nakamura S: Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int J Cancer. 83:625–629. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, et al: mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA. 102:719–724. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yu M, Shi Y, Zhang F, Zhou Y, Yang Y, Wei X, Zhang L and Niu R: Sequence variations of mitochondrial DNA D-loop region are highly frequent events in familial breast cancer. J Biomed Sci. 15:535–543. 2008. View Article : Google Scholar | |
|
Liu VW, Wang Y, Yang HJ, Tsang PCK, Ng TY, Wong LC, Nagley P and Ngan HY: Mitochondrial DNA variant 16189T>C is associated with susceptibility to endometrial cancer. Hum Mutat. 22:173–174. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Canter JA, Kallianpur AR, Parl FF and Millikan RC: Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 65:8028–8033. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang J, Asin-Cayuela J, Fish J, Michikawa Y, Bonafe M, Olivieri F, Passarino G, De Benedictis G, Franceschi C and Attardi G: Strikingly higher frequency in centenarians and twins of mtDNA mutation causing remodeling of replication origin in leukocytes. Proc Natl Acad Sci USA. 100:1116–1121. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Liou CW, Lin TK, Chen JB, Tiao MM, Weng SW, Chen SD, Chuang YC, Chuang JH and Wang PW: Association between a common mitochondrial DNA D-loop polycytosine variant and alteration of mitochondrial copy number in human peripheral blood cells. J Med Genet. 47:723–728. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Peng TI, Yu PR, Chen JY, Wang HL, Wu HY, Wei YH and Jou MJ: Visualizing common deletion of mitochondrial DNA-augmented mitochondrial reactive oxygen species generation and apoptosis upon oxidative stress. Biochim Biophys Acta. 1762:241–255. 2006. View Article : Google Scholar | |
|
Su X, Wang W, Ruan G, Liang M, Zheng J, Chen Y, Wu H, Fahey TJ III, Guan M and Teng L: A comprehensive characterization of mitochondrial genome in papillary thyroid cancer. Int J Mol Sci. 17:15942016. View Article : Google Scholar : | |
|
Wang Y, Liu VW, Xue WC, Tsang PC, Cheung AN and Ngan HY: The increase of mitochondrial DNA content in endometrial adenocarcinoma cells: A quantitative study using laser-captured microdissected tissues. Gynecol Oncol. 98:104–110. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Singh B, Owens KM, Bajpai P, Desouki MM, Srinivasasainagendra V, Tiwari HK and Singh KK: Mitochondrial DNA polymerase POLG1 disease mutations and germline variants promote tumorigenic properties. PLoS One. 10:e01398462015. View Article : Google Scholar : PubMed/NCBI | |
|
Reznik E, Miller ML, Şenbabaoğlu Y, Riaz N, Sarungbam J, Tickoo SK, Al-Ahmadie HA, Lee W, Seshan VE, Hakimi AA, et al: Mitochondrial DNA copy number variation across human cancers. eLife. 5:e107692016. View Article : Google Scholar : PubMed/NCBI | |
|
Booker LM, Habermacher GM, Jessie BC, Sun QC, Baumann AK, Amin M, Lim SD, Fernan-dez-Golarz C, Lyles RH, Brown MD, et al: North American white mitochondrial haplogroups in prostate and renal cancer. J Urol. 175:468–473. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Fang H, Shen L, Chen T, He J, Ding Z, Wei J, Qu J, Chen G, Lu J and Bai Y: Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer. 10:4212010. View Article : Google Scholar : PubMed/NCBI | |
|
Hu SP, Du JP, Li DR and Yao YG: Mitochondrial DNA haplogroup confers genetic susceptibility to nasopharyngeal carcinoma in Chaoshanese from Guangdong, China. PLoS One. 9:e877952014. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Beckman KB, Caberto C, Kazma R, Lum-Jones A, Haiman CA, Le Marchand L, Stram DO, Saxena R and Cheng I: Association of genes, pathways, and haplogroups of the mitochondrial genome with the risk of colorectal cancer: The multiethnic Cohort. PLoS One. 10:e01367962015. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang J, Zhao JH, Wang XL, Di JI, Liu ZB, Li GY, Wang MZ, Li Y, Chen R and Ge RL: Analysis of mitochondrial DNA in Tibetan gastric cancer patients at high altitude. Mol Clin Oncol. 3:875–879. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Poynter JN, Richardson M, Langer E, Hooten AJ, Roesler M, Hirsch B, Nguyen PL, Cioc A, Warlick E and Ross JA: Association between mitochondrial DNA haplogroup and myelodysplastic syndromes. Genes Chromosomes Cancer. 55:688–693. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Singh KK and Kulawiec M: Mitochondrial DNA polymorphism and risk of cancer. Methods Mol Biol. 471:291–303. 2009. View Article : Google Scholar | |
|
Yacoub HA, Mahmoud WM, El-Baz HA, Eid OM, El-Fayoumi RI, Mahmoud MM, Harakeh S and Abuzinadah OH: New haplotypes of the ATP synthase subunit 6 gene of mitochondrial DNA are associated with acute lymphoblastic leukemia in Saudi Arabia. Asian Pac J Cancer Prev. 15:10433–10438. 2014. View Article : Google Scholar | |
|
Cano D, Gomez CF, Ospina N, Cajigas JA, Groot H, Andrade RE and Torres MM: Mitochondrial DNA haplogroups and susceptibility to prostate cancer in a colombian population. ISRN Oncol. 2014:5306752014.PubMed/NCBI | |
|
Yu FY, Xu Q, Wu DD, Lau AT and Xu YM: The Prognostic and Clinicopathological roles of Sirtuin-3 in various cancers. PLoS One. 11:e01598012016. View Article : Google Scholar : PubMed/NCBI | |
|
Czarnecka AM, Krawczyk T, Plak K, Klemba A, Zdrozny M, Arnold RS, Kofler B, Golik P, Szybinska A, Lubinski J, et al: Mitochondrial genotype and breast cancer predisposition. Oncol Rep. 24:1521–1534. 2010.PubMed/NCBI | |
|
Verma M, Naviaux RK, Tanaka M, Kumar D, Franceschi C and Singh KK: Meeting report: Mitochondrial DNA and cancer epidemiology. Cancer Res. 67:437–439. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
van Gisbergen MW, Voets AM, Starmans MH, de Coo IF, Yadak R, Hoffmann RF, Boutros PC, Smeets HJ, Dubois L and Lambin P: How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models. Mutat Res Rev Mutat Res. 764:16–30. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Parker SJ and Metallo CM: Metabolic consequences of oncogenic IDH mutations. Pharmacol Ther. 152:54–62. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Reitman ZJ, Jin G, Karoly ED, Spasojevic I, Yang J, Kinzler KW, He Y, Bigner DD, Vogelstein B and Yan H: Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci USA. 108:3270–3275. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Burnichon N, Brière JJ, Libé R, Vescovo L, Rivière J, Tissier F, Jouanno E, Jeunemaitre X, Bénit P, Tzagoloff A, et al: SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet. 19:3011–3020. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang B, Wang J, Huang Z, Wei P, Liu Y, Hao J, Zhao L, Zhang F, Tu Y and Wei T: Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer. Oncotarget. 6:44495–44508. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Lin YF, Schulz AM, Pellegrino MW, Lu Y, Shaham S and Haynes CM: Maintenance and propagation of a deleterious mitochondrial genome by the mitochondrial unfolded protein response. Nature. 533:416–419. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
McMahon S and LaFramboise T: Mutational patterns in the breast cancer mitochondrial genome, with clinical correlates. Carcinogenesis. 35:1046–1054. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yu Y, Lv F, Lin H, Qian G, Jiang YS, Pang LX, Wang YP, Wang XF, Kang YM, Li CB, et al: Mitochondrial ND3 G10398A mutation: A biomarker for breast cancer. Genet Mol Res. 14:17426–17431. 2015. View Article : Google Scholar | |
|
Bai RK, Leal SM, Covarrubias D, Liu A and Wong LJ: Mitochondrial genetic background modifies breast cancer risk. Cancer Res. 67:4687–4694. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhu W, Qin W, Bradley P, Wessel A, Puckett CL and Sauter ER: Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis. 26:145–152. 2005. View Article : Google Scholar | |
|
Wang Y, Liu VW, Tsang PC, Chiu PM, Cheung AN, Khoo US, Nagley P and Ngan HY: Microsatellite instability in mitochondrial genome of common female cancers. Int J Gynecol Cancer. 16(Suppl 1): 259–266. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Bianchi MS, Bianchi NO and Bailliet G: Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. Cytogenet Cell Genet. 71:99–103. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Shakhssalim N, Houshmand M, Kamalidehghan B, Faraji A, Sarhangnejad R, Dadgar S, Mobaraki M, Rosli R and Sanati MH: The mitochondrial C16069T polymorphism, not mitochondrial D310 (D-loop) mononucleotide sequence variations, is associated with bladder cancer. Cancer Cell Int. 13:1202013. View Article : Google Scholar : PubMed/NCBI | |
|
Tipirisetti NR, Govatati S, Pullari P, Malempati S, Thupurani MK, Perugu S, Guruvaiah P, Rao KL, Digumarti RR, Nallanchakravarthula V, et al: Mitochondrial control region alterations and breast cancer risk: A study in South Indian population. PLoS One. 9:e853632014. View Article : Google Scholar : PubMed/NCBI | |
|
Fendt L, Niederstätter H, Huber G, Zelger B, Dünser M, Seifarth C, Röck A, Schäfer G, Klock-er H and Parson W: Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdis-section. Breast Cancer Res Treat. 128:327–336. 2011. View Article : Google Scholar | |
|
Ebner S, Lang R, Mueller EE, Eder W, Oeller M, Moser A, Koller J, Paulweber B, Mayr JA, Sperl W, et al: Mitochondrial haplogroups, control region polymorphisms and malignant melanoma: A study in middle European Caucasians. PLoS One. 6:e271922011. View Article : Google Scholar : PubMed/NCBI | |
|
Wang CY, Wang HW, Yao YG, Kong QP and Zhang YP: Somatic mutations of mitochondrial genome in early stage breast cancer. Int J Cancer. 121:1253–1256. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Czarnecka AM, Klemba A, Krawczyk T, Zdrozny M, Arnold RS, Bartnik E and Petros JA: Mitochondrial NADH-dehydrogenase polymorphisms as sporadic breast cancer risk factor. Oncol Rep. 23:531–535. 2010.PubMed/NCBI | |
|
Weigl S, Paradiso A and Tommasi S: Mitochondria and familial predisposition to breast cancer. Curr Genomics. 14:195–203. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Li L, Chen L, Li J, Zhang W, Liao Y, Chen J and Sun Z: Correlational study on mitochondrial DNA mutations as potential risk factors in breast cancer. Oncotarget. 7:31270–31283. 2016.PubMed/NCBI | |
|
Rohan TE, Wong LJ, Wang T, Haines J and Kabat GC: Do alterations in mitochondrial DNA play a role in breast carcinogenesis? J Oncol. 2010:6043042010. View Article : Google Scholar : PubMed/NCBI | |
|
Covarrubias D, Bai RK, Wong LJ and Leal SM: Mitochondrial DNA variant interactions modify breast cancer risk. J Hum Genet. 53:924–928. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Darvishi K, Sharma S, Bhat AK, Rai E and Bamezai RN: Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett. 249:249–255. 2007. View Article : Google Scholar | |
|
Tengku Baharudin N, Jaafar H and Zainuddin Z: Association of mitochondrial DNA 10398 polymorphism in invasive breast cancer in malay population of peninsular malaysia. Malays J Med Sci. 19:36–42. 2012.PubMed/NCBI | |
|
Tan DJ, Bai RK and Wong LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. 62:972–976. 2002.PubMed/NCBI | |
|
Gallardo ME, Moreno-Loshuertos R, López C, Casqueiro M, Silva J, Bonilla F, Rodríguez de Córdoba S and Enríquez JA: m.6267G>A: a recurrent mutation in the human mitochondrial DNA that reduces cytochrome c oxidase activity and is associated with tumors. Hum Mutat. 27:575–582. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Aral C, Kaya H, Ataizi-Celikel C, Akkiprik M, Sonmez O, Gulluoglu BM and Ozer A: A novel approach for rapid screening of mitochondrial D310 polymorphism. BMC Cancer. 6:212006. View Article : Google Scholar : PubMed/NCBI | |
|
Ma Y, Bai RK, Trieu R and Wong LJ: Mitochondrial dysfunction in human breast cancer cells and their transmitochondrial cybrids. Biochim Biophys Acta. 1797:29–37. 2010. View Article : Google Scholar | |
|
Santos GC Jr, Góes AC, Vitto H, Moreira CC, Avvad E, Rumjanek FD and Moura Gallo CV: Genomic instability at the 13q31 locus and somatic mtDNA mutation in the D-loop site correlate with tumor aggressiveness in sporadic Brazilian breast cancer cases. Clinics (São Paulo). 67:1181–1190. 2012. View Article : Google Scholar | |
|
Xu C, Tran-Thanh D, Ma C, May K, Jung J, Vecchiarelli J and Done SJ: Mitochondrial D310 mutations in the early development of breast cancer. Br J Cancer. 106:1506–1511. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, Nicol T, Gabriel-son E, Cuomo C, Cohen D, et al: Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 61:7623–7626. 2001.PubMed/NCBI | |
|
Alhomidi MA, Vedicherla B, Movva S, Rao PK, Ahuja YR and Hasan Q: Mitochondrial D310 instability in Asian Indian breast cancer patients. Tumour Biol. 34:2427–2432. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lott MT, Leipzig JN, Derbeneva O, Xie HM, Chalkia D, Sarmady M, Procaccio V and Wallace DC: mtDNA variation and analysis using mitomap and mitomaster. Curr Protoc Bioinformatics. 44:1.23.1–1.23.26. 2013. View Article : Google Scholar | |
|
Payne BA, Wilson IJ, Yu-Wai-Man P, Coxhead J, Deehan D, Horvath R, Taylor RW, Samuels DC, Santibanez-Koref M and Chinnery PF: Universal heteroplasmy of human mitochondrial DNA. Hum Mol Genet. 22:384–390. 2013. View Article : Google Scholar | |
|
Weerts MJ, Sieuwerts AM, Smid M, Look MP, Foekens JA, Sleijfer S and Martens JW: Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis. Oncotarget. 7:29166–29176. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Mueller EE, Brunner SM, Mayr JA, Stanger O, Sperl W and Kofler B: Functional differences between mitochondrial haplogroup T and haplogroup H in HEK293 cybrid cells. PLoS One. 7:e523672012. View Article : Google Scholar | |
|
Tommasi S, Favia P, Weigl S, Bianco A, Pilato B, Russo L, Paradiso A and Petruzzella V: Mitochondrial DNA variants and risk of familial breast cancer: An exploratory study. Int J Oncol. 44:1691–1698. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Blein S, Bardel C, Danjean V, McGuffog L, Healey S, Barrowdale D, Lee A, Dennis J, Kuchenbaecker KB, Soucy P, et al: Breast Cancer Family Registry; EMBRACE; GEMO Study Col-laborators; HEBON: An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res. 17:612015. View Article : Google Scholar | |
|
Rao R, Rivers A, Rahimi A, Wooldridge R, Rao M, Leitch M, Euhus D and Haley BB: Genetic ancestry using mitochondrial DNA in patients with triple-negative breast cancer (GAMiT study). Cancer. 123:107–113. 2017. View Article : Google Scholar | |
|
Mosquera-Miguel A, Alvarez-Iglesias V, Carracedo A, Salas A, Vega A, Carracedo A, Milne R, de León AC, Benitez J, Carracedo A, et al: Is mitochondrial DNA variation associated with sporadic breast cancer risk. Cancer Res. 68:623–625; author reply 624. 2008. View Article : Google Scholar | |
|
van Oven M and Kayser M: Updated comprehensive phylogenetic tree of global human mitochondrial DNA variation. Hum Mutat. 30:E386–E394. 2009. View Article : Google Scholar | |
|
Salas A, García-Magariños M, Logan I and Bandelt HJ: The saga of the many studies wrongly associating mitochondrial DNA with breast cancer. BMC Cancer. 14:6592014. View Article : Google Scholar : PubMed/NCBI | |
|
Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, et al: Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer. JAMA. 295:1379–1388. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Hossein R and Houshmand M: Diagnostic algorithm for identification of individuals with hereditary predisposition to breast cancer. Lik Sprava. 1–2:103–108. 2008. | |
|
Jandova J, Janda J and Sligh JE: Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis. Exp Cell Res. 318:2215–2225. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Q, Liang Z, Gao Y, Teng M and Niu L: Differentially expressed mitochondrial genes in breast cancer cells: Potential new targets for anti-cancer therapies. Gene. 596:45–52. 2017. View Article : Google Scholar | |
|
Lin CS, Chang SC, Ou LH, Chen CM, Hsieh SS, Chung YP, King KL, Lin SL and Wei YH: Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma. Oncol Rep. 33:2924–2934. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Blein S, Barjhoux L, Damiola F, Dondon MG, Eon-Marchais S, Marcou M, Caron O, Lortholary A, Buecher B, Vennin P, et al GENESIS investigators: Targeted sequencing of the mitochondrial genome of women at high risk of breast cancer without detectable mutations in BRCA1/2. PLoS One. 10:e01361922015. View Article : Google Scholar : PubMed/NCBI | |
|
Hsu CW, Yin PH, Lee HC, Chi CW and Tseng LM: Mitochondrial DNA content as a potential marker to predict response to anthra-cycline in breast cancer patients. Breast J. 16:264–270. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Farnie G, Sotgia F and Lisanti MP: High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant. Oncotarget. 6:30472–30486. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Ferreri AJ, Ponzoni M, Guidoboni M, Resti AG, Politi LS, Cortelazzo S, Demeter J, Zallio F, Palmas A, Muti G, et al: Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial. J Natl Cancer Inst. 98:1375–1382. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lamb R, Harrison H, Hulit J, Smith DL, Lisanti MP and Sotgia F: Mitochondria as new therapeutic targets for eradicating cancer stem cells: Quantitative proteomics and functional validation via MCT1/2 inhibition. Oncotarget. 5:11029–11037. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Ferreri AJ, Ponzoni M, Guidoboni M, De Conciliis C, Resti AG, Mazzi B, Lettini AA, De-meter J, Dell'Oro S, Doglioni C, et al: Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol. 23:5067–5073. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Teixeira FK, Sanchez CG, Hurd TR, Seifert JRK, Czech B, Preall JB, Hannon GJ and Lehmann R: ATP synthase promotes germ cell differentiation independent of oxidative phosphorylation. Nat Cell Biol. 17:689–696. 2015. View Article : Google Scholar : PubMed/NCBI |
